These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

692 related articles for article (PubMed ID: 19324483)

  • 21. Predictors of vascular access thrombosis among patients on the cadaveric renal transplantation waiting list.
    Akman B; Afsar B; Ataç FB; Ibis A; Arat Z; Sezer S; Ozdemir FN; Haberal M
    Transplant Proc; 2006 Mar; 38(2):413-5. PubMed ID: 16549134
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Survival of vascular access during daily and three times a week hemodialysis.
    Quintaliani G; Buoncristiani U; Fagugli R; Kuluiranu H; Ciao G; Rondini L; Lowenthal DT; Reboldi G
    Clin Nephrol; 2000 May; 53(5):372-7. PubMed ID: 11305810
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Homocysteine and vascular access thrombosis in end-stage renal disease patients: a retrospective study.
    Bowden RG; Wyatt FB; Wilson R
    J Nephrol; 2002; 15(6):666-70. PubMed ID: 12495281
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Obesity as a predictor of vascular access outcomes: analysis of the USRDS DMMS Wave II study.
    Chan MR; Young HN; Becker YT; Yevzlin AS
    Semin Dial; 2008; 21(3):274-9. PubMed ID: 18397205
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of high-flux hemodialysis on renal anemia.
    Ayli D; Ayli M; Azak A; Yüksel C; Kosmaz GP; Atilgan G; Dede F; Abayli E; Camlibel M
    J Nephrol; 2004; 17(5):701-6. PubMed ID: 15593038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of using recombinant human erythropoietin on the effectiveness of hemodialysis in children with terminal renal failure].
    Pietrzyk JA; Dyras P; Smolnik T; Szymowska M
    Przegl Lek; 1992; 49(1-2):61-5. PubMed ID: 1280842
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of a quality improvement programme based on vascular access flow monitoring on costs, access occlusion and access failure.
    Wijnen E; Planken N; Keuter X; Kooman JP; Tordoir JH; de Haan MW; Leunissen KM; van der Sande F
    Nephrol Dial Transplant; 2006 Dec; 21(12):3514-9. PubMed ID: 16921189
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Catheter dysfunction and dialysis performance according to vascular access among 736 critically ill adults requiring renal replacement therapy: a randomized controlled study.
    Parienti JJ; Mégarbane B; Fischer MO; Lautrette A; Gazui N; Marin N; Hanouz JL; Ramakers M; Daubin C; Mira JP; Charbonneau P; du Cheyron D;
    Crit Care Med; 2010 Apr; 38(4):1118-25. PubMed ID: 20154599
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship between clinical outcomes and vascular access type among hemodialysis patients with Staphylococcus aureus bacteremia.
    Inrig JK; Reed SD; Szczech LA; Engemann JJ; Friedman JY; Corey GR; Schulman KA; Reller LB; Fowler VG
    Clin J Am Soc Nephrol; 2006 May; 1(3):518-24. PubMed ID: 17699254
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of intradialytic versus home-based aerobic exercise training on physical function and vascular parameters in hemodialysis patients: a randomized pilot study.
    Koh KP; Fassett RG; Sharman JE; Coombes JS; Williams AD
    Am J Kidney Dis; 2010 Jan; 55(1):88-99. PubMed ID: 19932545
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Haemoglobin level and vascular access survival in haemodialysis patients.
    Garrancho JM; Kirchgessner J; Arranz M; Klinkner G; Rentero R; Ayala JA; Marcelli D
    Nephrol Dial Transplant; 2005 Nov; 20(11):2453-7. PubMed ID: 16077146
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The association between pulse pressure and vascular access thrombosis in chronic hemodialysis patients.
    Chou CY; Liu JH; Kuo HL; Liu YL; Lin HH; Yang YF; Wang SM; Huang CC
    Hypertens Res; 2009 Aug; 32(8):712-5. PubMed ID: 19590503
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of recombinant human erythropoietin on hospitalization of hemodialysis patients.
    Churchill DN; Muirhead N; Goldstein M; Posen G; Fay W; Beecroft ML; Gorman J; Taylor DW
    Clin Nephrol; 1995 Mar; 43(3):184-8. PubMed ID: 7774076
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of mean weekly epoetin alfa dose with mortality risk in a retrospective cohort study of Medicare hemodialysis patients.
    Weinhandl ED; Gilbertson DT; Collins AJ
    Am J Nephrol; 2011; 34(4):298-308. PubMed ID: 21829009
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical protocol. A phase IIb, randomized, multicenter, double-blind study of the efficacy and safety of Trinam (EG004) in stenosis prevention at the graft-vein anastomosis site in dialysis patients.
    Fuster V; Charlton P; Boyd A
    Hum Gene Ther; 2001 Nov; 12(16):2025-7. PubMed ID: 11727735
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lymphocyte 5'-nucleotidase and aminopeptidase N activity in patients on maintenance hemodialysis treated with human recombinant erythropoietin and 1-alpha-D3.
    Stefanovic V; Mitić-Zlatkovic M; Radivojevic J; Vlahovic P
    Ren Fail; 2005; 27(3):283-8. PubMed ID: 15957544
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Optimal therapy with erythropoietin (EPO) in patients with renal anemia on hemodialysis therapy].
    Merta M; Sobotová D; Zahálková J; Bitterová Z; Jirka T; Knetl P; Kopenec J; Suchanová J; Vlasák J
    Sb Lek; 2001; 102(1):41-52. PubMed ID: 11830918
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trends in patient characteristics and first-year medical costs of older incident hemodialysis patients, 1995-2005.
    Mau LW; Liu J; Qiu Y; Guo H; Ishani A; Arneson TJ; Gilbertson DT; Dunning SC; Collins AJ
    Am J Kidney Dis; 2010 Mar; 55(3):549-57. PubMed ID: 20116913
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Switching from subcutaneous to intravenous erythropoietin alpha in haemodialysis patients requires a major dose increase.
    Galliford JW; Malasana R; Farrington K
    Nephrol Dial Transplant; 2005 Sep; 20(9):1956-62. PubMed ID: 15930017
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hyperhomocysteinaemia and vascular access thrombosis among chronic hemodialysis patients in Taiwan: a retrospective study.
    Chen TC; Wang IK; Lee CH; Chang HW; Chiou TT; Lee CT; Fang JT; Wu MS; Hsu KT; Yang CC; Wang PH; Chuang FR
    Int J Clin Pract; 2006 Dec; 60(12):1596-9. PubMed ID: 16704682
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.